In vitro and in vivo determination of anti-TNFα activity in canine plasma from donors subject to preconditioning with endotoxin
© BioMed Central Ltd 2007
Published: 26 September 2007
Septic shock is characterized by cardiovascular and vasomotor failure that is induced by an uncontrolled cascade of inflammatory mediators such as TNFα, IL-1β and IL-6. In dogs, systemic bacterial infections, haemorrhage, trauma, gastric dilatation/volvulus and pancreatitis are the major causes of septic shock. While endotoxin is a recognized effector molecule that can initiate an inflammatory cascade, it has been reported that preconditioning with endotoxin can downregulate inflammatory cytokine responses to subsequent endotoxin challenge. This study reports the effect of endotoxin preconditioning on anti-TNFα activity present in plasma from canine donors.
Materials and methods
Plasma from preconditioned (Caniplas®) and normal dogs (FFP) was provided blind to the study by a commercial supplier (Plasvacc Pty Ltd). In vitro anti-TNFα activity in canine donor plasma was determined by a L929 murine cell TNFα inhibition bioassay using recombinant murine TNFα. In vivo effects were tested by a rat subcutaneous skin pouch model. Rats were pretreated for 3 days with either Caniplas®, FFP, saline (2 ml/day, s.c.) or carprofen (5 mg/kg, s.c.) and inflammation was induced by injecting monosodium urate crystals into the pouch (5 mg/ml in 5 ml saline). Fluid was taken from pouches at specified intervals for cell count, TNFα and IL-6 analysis. Data analysis: normalized data were fitted to a four-parameter logistic curve. The fitted midpoints were compared statistically for datasets using an F-test and calculated fitted hill slopes.
While we need to confirm the mechanism, we report that preconditioning with endotoxin does illicit specific anti-TNFα activity and that this observation has been confirmed in both in vitro testing and in vivo animal models. It is plausible that preconditioning animals with endotoxin induces an increase in the concentration of soluble TNFα receptors I and II in donor plasma, and that this is the probable source of TNFα antagonism. This report suggests that preconditioned plasma may be a beneficial treatment where inflammation causes increased expression of TNFα.